These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 37120729)
1. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Güran M; Çakıral K; Teralı K; Kandemir T; Şanlıtürk G; Öcal MM; Nagiyev T; Köksal F Pathog Dis; 2023 Jan; 81():. PubMed ID: 37120729 [TBL] [Abstract][Full Text] [Related]
2. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
3. The synergic and addictive activity of biogenic silver nanoparticle associated with meropenem against carbapenem-resistant Acinetobacter baumannii. Allend SO; Oliveira Garcia M; da Cunha KF; de Albernaz DTF; Panagio LA; Nakazaro G; Reis GF; Oliveira TL; Neto ACPS; Hartwig DD J Appl Microbiol; 2024 Mar; 135(3):. PubMed ID: 38383758 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii. Ni W; Wang Y; Ma X; He Y; Zhao J; Guan J; Li Y; Gao Z Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1451-1457. PubMed ID: 36201141 [TBL] [Abstract][Full Text] [Related]
6. In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii. Wang Y; Li X; Wang D; Sun S; Lu C Lett Appl Microbiol; 2020 Mar; 70(3):189-195. PubMed ID: 31808159 [TBL] [Abstract][Full Text] [Related]
7. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility. Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655 [TBL] [Abstract][Full Text] [Related]
8. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Kiratisin P; Apisarnthanarak A; Kaewdaeng S Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913 [TBL] [Abstract][Full Text] [Related]
9. Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii. Mohd Sazlly Lim S; Heffernan AJ; Zowawi HM; Roberts JA; Sime FB Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1943-1952. PubMed ID: 33884516 [TBL] [Abstract][Full Text] [Related]
10. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Lee S; Razqan GS; Kwon DH Phytomedicine; 2017 Jan; 24():49-55. PubMed ID: 28160861 [TBL] [Abstract][Full Text] [Related]
12. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Müderris T; Dursun Manyaslı G; Sezak N; Kaya S; Demirdal T; Gül Yurtsever S Eur J Med Res; 2024 Jun; 29(1):331. PubMed ID: 38880888 [TBL] [Abstract][Full Text] [Related]
13. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385 [TBL] [Abstract][Full Text] [Related]
14. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections. Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600 [TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of exogenous glutathione and its synergism on antibiotics sensitize carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Alharbe R; Almansour A; Kwon DH Int J Med Microbiol; 2017 Oct; 307(7):409-414. PubMed ID: 28781060 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368 [TBL] [Abstract][Full Text] [Related]
17. In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii. Ju YG; Lee HJ; Yim HS; Lee MG; Sohn JW; Yoon YK Sci Rep; 2022 May; 12(1):7541. PubMed ID: 35534512 [TBL] [Abstract][Full Text] [Related]
18. A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam. Chaiben V; Yamada CH; Telles JP; de Andrade AP; Arend LNVS; Ribeiro VST; Dantas LR; Suss PH; Tuon FF J Antimicrob Chemother; 2022 May; 77(6):1676-1684. PubMed ID: 35368079 [TBL] [Abstract][Full Text] [Related]